Hui Wang

ORCID: 0000-0001-6545-3826 · 52 papers in corpus
lab-animal 2022
Molecular medicine (Cambridge, Mass.) ·doi:10.1186/s10020-022-00582-6

BACKGROUND: Endometriosis (EMS) is a "tumour-like" gynaecological disease with distant metastasis, and studies have shown that EMS can induce distant metastasis through vascular vessels, but the driving factors and their mechanism are not c…

lab-animal 2022
·doi:10.21203/rs.3.rs-1757587/v1

Abstract Background Endometriosis (EMS) is a "tumor-like" gynecological disease with distant metastasis, and studies have shown that EMS can carry out distant metastasis through vascular vessels, but the driving factor and its mechanism is …

other 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIG…

observational 2021
·doi:10.21203/rs.3.rs-930037/v1

Abstract Background : Intrauterine insemination (IUI) treatment is recommended in subfertile women with AFS/ASRM stage I/II endometriosis. However, the efficacy of IUI in women with ovarian endometriomas with tubal patency is uncertain. We …

lab-animal 2021
Annals of translational medicine ·doi:10.21037/atm-21-3334

BACKGROUND: The human leukocyte antigen G5 subtype (HLA-G5) is a major histocompatibility complex (MHC) molecule that is selectively expressed at the maternal-foetal tissue interface and is required for the successful implantation of the in…

nonrandomized-trial 2021
BMC women's health ·doi:10.1186/s12905-021-01385-3

BACKGROUND: Elagolix is an oral, gonadotropin-releasing hormone (GnRH) receptor antagonist, that significantly reduces dysmenorrhea and non-menstrual pelvic pain (NMPP) in women with moderate to severe endometriosis-associated pain. METHOD…

lab-animal 2021
Journal of ethnopharmacology ·doi:10.1016/j.jep.2021.113996

ETHNOPHARMACOLOGICAL RELEVANCE: Bu Shen Huo Xue Tang (BSHXT) is a traditional Chinese medicine formula that is clinically used in the treatment of premature ovarian insufficiency (POI). However, its therapeutic mechanism remains unclear. A…

lab-animal 2021
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-021-00844-8

BACKGROUND: Endometriosis, the presence of active endometrial tissue outside the lining membrane of the uterine cavity, is a common disease in women of childbearing age. The ectopic endometrium has some characteristics of tumor tissue, incl…

review 2020
Annals of translational medicine ·doi:10.21037/atm.2020.02.53

Adhesion is a postoperative complication that has plagued gynecologists for many years, as 60-90% of gynecological patients develop adhesions after abdominopelvic surgeries. Abdominopelvic adhesions could lead to chronic pelvic pain, infert…

rct 2020
·doi:10.1097/01.aog.0000663140.66314.38

INTRODUCTION: Evaluate the efficacy of elagolix with add-back therapy on menstrual blood loss (MBL) and safety in women with uterine fibroids (UF), heavy menstrual bleeding (HMB) and adenomyosis. METHODS: Pooled data from two investigationa…

lab-animal 2020
Cell cycle (Georgetown, Tex.) ·doi:10.1080/15384101.2020.1831254

Pancreatic cancer (PC) is a leading cause of cancer mortality and is expected to continue increasing incidence. Abnormally expressed microRNAs have been demonstrated tightly correlated with the development and progression of PC. However, th…

review 2019
Reproduction (Cambridge, England) ·doi:10.1530/rep-18-0523

Artificial intelligence (AI) has experienced rapid growth over the past few years, moving from the experimental to the implementation phase in various fields, including medicine. Advances in learning algorithms and theories, the availabilit…

lab-animal 2018
Nature communications ·doi:10.1038/s41467-018-03590-5

Chemoresistance is a major unmet clinical obstacle in ovarian cancer treatment. Epigenetics plays a pivotal role in regulating the malignant phenotype, and has the potential in developing therapeutically valuable targets that improve the di…

observational 2018
Experimental and therapeutic medicine ·doi:10.3892/etm.2018.6840

Fluctuations of interleukin-1β (IL-1β) and heparin-binding epidermal growth factor (HB-EGF) in endometrial receptivity were detected. Seventy-two patients receiving in vitro fertilization-embryo transfer (IVF-ET) for the first time in Yanta…

2018
·doi:10.1097/01.aog.0000533387.12236.72

INTRODUCTION: To evaluate the long-term effect of elagolix, an oral, non-peptide GnRH antagonist, on bone mineral density (BMD) in two 6-month (M) extension studies (Elaris EM-III and IV) of the pivotal, 6M, phase 3 studies (12M overall tre…

other 2017
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-016-0862-6

PURPOSE: Differential methylation of both HOXA10 and catechol-O-methyltransferase (COMT) has been reported in different endometrium disorders, and the two genes are linked through the estrogen pathway. The current study investigates the DNA…

lab-animal 2017
Scientific reports ·doi:10.1038/s41598-017-08249-7

Type I epithelial ovarian cancer (EOC) is primarily resistant to platinum-based chemotherapies and needs novel therapeutics. Given the aberrant Wnt activation in type I EOC and the involvement of Dapper1 Antagonist of Catenin-1 (DACT1) in W…

observational 2016
Oncotarget ·doi:10.18632/oncotarget.8245

BACKGROUND: Most cervical cancer patients worldwide receive surgical treatments, and yet the current International Federation of Gynecology and Obstetrics (FIGO) staging system do not consider surgical-pathologic data. We propose a more com…

2012

Objective:To explore intrauterine device on Mirena in the treatment of uterine glands of myopathy clinical efficacy and side effects.Methods:observed 48 cases in patients with uterine gland myopathy placed on Mirena before and after dysmeno…

nonrandomized-trial 2012

Objective To observe Danzhuxiaoyifang combined with laparoscopy on serum IL-8 of infertile patients with mild endometriosis.Methods 50 patients were divided into 2 groups,the treat group was given Traditional Chinese Medicine after laparosc…

lab-animal 2012
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2012.05.020

OBJECTIVE: To investigate whether omentectomy is required in the operation for ovarian cancer, in particular at the early stage. STUDY DESIGN: F344 nude rats were divided into two groups: one in which laparotomy and omentectomy were perfor…

2010

Objective To study the features of pathologic morphology and the expressions of p53,cyclin E,CD44_(V6)in clear cell carcinoma,and their relationship with patients' survival.Methods Twenty-four patients with clear cell carcinoma of ovary (CC…

observational 2009

Objective:To explore the expression of tumor necrosis factor(TNF)and vascular endothelial growth factors(VEGF)in both serum and peritoneal fluid of endometriosis patients and to evaluate the functions of them in the pathogenesis of endometr…

lab-animal 2008
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

OBJECTIVE: To explore the mechanism of inhibitory effect of SLW on estrogen production by endometrial cells of endometriosis. METHOD: After the model of eutopic primary cultured endometrial cells of endometiosis and hysteromyoma in vitro w…

2003

Purpose To observe the curative effect of acupoint application on endometriosis.Methods Application of Qili San, a Chinese patent medicine, to a body point Shenque (CV 8) plus moxibustion with moxa sticks was used to treat 31 patients with …